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Abstract 
Background 
Whole-genome sequencing is an important tool for understanding microbial evolution 
and identifying the emergence of functionally important variants over the course of 
epidemics.  In October 2010, a severe cholera epidemic began in Haiti, with 
additional cases identified in the neighboring Dominican Republic.  We used whole-
genome approaches to sequence four Vibrio cholerae isolates from Haiti and the 
Dominican Republic and three additional V. cholerae isolates to a high depth of 
coverage (>2000x); four of the seven isolates were previously sequenced.   
Results 
Using these sequence data, we examined the effect of depth of coverage and 
sequencing platform on genome assembly and identification of sequence variants.  
We found that 50x coverage is sufficient to construct a whole-genome assembly and 
to accurately call most variants from 100 base pair paired-end sequencing reads.  
Phylogenetic analysis between the newly sequenced and thirty-three previously 
sequenced V. cholerae isolates indicates that the Haitian and Dominican Republic 
isolates are closest to strains from South Asia.  The Haitian and Dominican Republic 
isolates form a tight cluster, with only four variants unique to individual isolates.  
These variants are located in the CTX region, the SXT region, and the core genome.  
Of the 126 mutations identified that separate the Haiti-Dominican Republic cluster 
from the V. cholerae reference strain (N16961), 73 are non-synonymous changes, and 
a number of these changes cluster in specific genes and pathways. 
Conclusions   - 4 - 
Sequence variant analyses of V. cholerae isolates, including multiple isolates from the 
Haitian outbreak, identify coverage-specific and technology-specific effects on 
variant detection, and provide insight into genomic change and functional evolution 
during an epidemic. 
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Whole-genome sequencing; Vibrio cholerae; Haitian cholera epidemic; microbial 
evolution 
Background  
Following the 2010 earthquake in Haiti, a cholera outbreak began in Haiti’s 
Artibonite Department and rapidly spread across the country.  As of March 18, 2012, 
a total of 531,683 cholera cases have been reported in Haiti, with 7056 deaths due to 
the epidemic (http://www.mspp.gouv.ht).  Cholera cases were also reported in the 
Dominican Republic [1][2], and cases linked to the outbreak strain have been 
documented in travelers returning to their home countries from both Haiti and the 
Dominican Republic [3][1]. 
The absence of a previously recorded history of epidemic cholera in Haiti [4] raised 
interest in understanding the source of this outbreak.  In order to further characterize 
the Haitian cholera strain, initial studies applied pulsed field gel electrophoresis and 
variable number tandem repeat typing to a large number of microbial isolates from the 
Haitian cholera outbreak [5][6].  These analyses identified the Haitian cholera strain 
as V. cholerae O1 El Tor, placing it as a seventh pandemic strain.  In general, these 
studies found low levels of genetic variation in isolates, supporting a point-source 
origin for the outbreak [5][6][7].   - 5 - 
More than a year has elapsed since V. cholerae was first introduced into Haiti.  
Identifying novel microbial variants that have emerged over the course of the 
outbreak may provide insight into the organism’s evolution on a short time scale.  
Genomic sequencing is the most powerful approach for evaluating such microbial 
evolution.  Next-generation sequencing technologies, including Illumina, PacBio, and 
454 sequencing, have increased the speed and decreased the cost of genome-wide 
sequencing.  Chin et al. sequenced two V. cholerae isolates from Haiti using PacBio 
sequencing, which produces longer reads but has a higher error rate than other next-
generation approaches [8].  Reimer et al. used single-end Illumina-based sequencing 
to sequence eight V. cholerae isolates from Haiti and one from the Dominican 
Republic [9].  Hendriksen et al. compared Haitian V. cholerae sequences to sequences 
from Nepal, finding that the Haitian isolates are highly similar to a set of isolates 
collected in Nepal in the summer of 2010 [10].  These sequencing studies indicated 
that the Haitian epidemic is most closely related to seventh pandemic strains from 
South Asia, and that the Dominican Republic outbreak strain is genetically nearly 
identical to the Haitian outbreak strain.  The recent study of Hasan et al. [11] 
identified non-O1/O139 V. cholerae strains in patients in Haiti, and additional work is 
needed to explore the potential contribution of such strains to disease in Haiti. 
In this study, we used paired-end Illumina sequencing at a high depth of coverage to 
sequence one V. cholerae isolate from the Dominican Republic, three isolates from 
Haiti, and three additional V. cholerae isolates. Four of the isolates were previously 
sequenced using a variety of sequencing technologies [12][13][8] , and we present a 
comparison between sequence data generated using Sanger-based, next-generation, 
and PacBio sequencing technologies.  The sequenced isolates include a classical O1-
serogroup isolate from the sixth pandemic and an O139-serogroup strain as well as   - 6 - 
O1 El Tor strains from the seventh pandemic.  The diverse strains sequenced and the 
high depth of coverage allow us to probe the sequence coverage required for optimal 
assembly and variant calling of the V. cholerae genome using next generation 
sequencing.  Our data characterize the depth of coverage needed to accurately resolve 
sequence variation between V. cholerae strains. 
We further identify sequence differences between the Haitian and Dominican 
Republic isolates in comparison to previously published and newly sequenced 
worldwide samples, and in comparison to each other.  The three isolates from Haiti 
were collected in the same hospital in the Artibonite Department in October, 2010.  
The Dominican Republic isolate was collected three months later, in connection with 
a cholera outbreak among guests returning from a wedding in the Dominican 
Republic [1]. Since epidemic cholera had not been reported in Hispaniola prior to 
2010, examining microbial mutations as the outbreak spread from Haiti to the 
Dominican Republic three months later provides insight into the temporal evolution 
of epidemic V. cholerae. 
Results and discussion 
Sequencing seven V. cholerae isolates at high depth of coverage 
We sequenced seven V. cholerae isolates, including three isolates from Haiti (H1*, 
H2* and H3), one from the Dominican Republic (DR1), two from Bangladesh 
(N16961* and DB_2002), and one from India (O395*).  Four of these isolates (H1*, 
H2*, N16961*, and O395*) were previously sequenced using a variety of sequencing 
technologies and to varying depths, and are denoted with an asterisk.  We sequenced 
all strains to high depths of coverage (2643 – 5631x; Supplementary Table S6).  We   - 7 - 
have deposited the sequence data in the Sequence Read Archive database 
(Submission: SRA056415). 
Effect of depth of coverage on genome assembly and single-nucleotide 
polymorphism (SNP) calling 
The high depth of coverage of our sequencing enabled comparison of the efficacy of 
de novo assembly and variant detection at multiple depths of coverage.  To assess the 
assembly quality, we used the N50 statistic.  N50, a common metric of assembly 
quality, is the number of base pairs in the longest contig C such that fewer than half of 
the base pairs in the genome lie in contigs that are longer than C.  We selected a 
random sample of the total reads for each isolate and compared the median N50 value 
for assemblies produced by Velvet at a range of coverage depths (5x to 250x), with 
three random read samples at each depth of coverage.  For most isolates, N50 is stable 
across the range of depths from 50x to 250x, suggesting that 50x coverage is 
sufficient to construct a de novo assembly for these samples (Figure 1A).  However, 
N50 continues to increase up to 100x coverage in sample H1*.  The average read 
quality in H1* is the lowest of all the samples (Supplementary Figure S4), suggesting 
that while 50x is sufficient depth of coverage for de novo genome assembly on most 
samples, greater coverage is needed when average base quality is low. 
We explored the effect of depth of coverage on calling sequence variants by 
examining the SNPs, insertions, and deletions identified at a range of coverage depths 
(5x to 250x).  For all isolates, the number of SNPs identified increases sharply up to 
50x coverage, and continues to increase gradually after this point (Figure 1B).  In six 
of the seven isolates, at least 85% of the SNPs identified at 250x coverage are also 
identified at 50x coverage (the exception was the O395 sample, since at 50x coverage,   - 8 - 
we did not detect one of the three SNPs found at 250x coverage).  SNPs identified 
uniquely at higher depths of coverage include variants in regions where the average 
base quality is low, regions with unusually low depths of coverage compared to the 
rest of the genome, and regions with false positive calls due to misalignment of reads 
across a deletion.  Fifty-fold coverage is also sufficient to identify nearly all of the 
insertions and deletions observed at higher depths of coverage (Figure 1C).  At 50x 
coverage, we detected at least 98% of the insertions and deletions observed at 250x 
coverage in each isolate.  Twenty-fold coverage is sufficient to detect the majority of 
insertions and deletions; at least 90% of insertions and deletions that are observed at 
250x coverage are also found at 20x coverage in five of the seven isolates.  These 
results suggest that 50x coverage is sufficient to accurately call most variants, 
although deeper coverage provides additional power for identifying SNPs in some 
genomic regions. 
Comparison of sequence variants, insertions, and deletions identified using 
multiple sequencing approaches 
Four of our isolates were previously sequenced using a variety of platforms.  Those 
sequencing results provide an opportunity for us to compare variant calls across 
sequencing technologies, validate variant calls, and identify potential errors in 
reference sequences. 
Comparison to N16961 Sanger reference sequences 
The original reference genome for V. cholerae was the Sanger-sequenced N16961 
genome [12].  Feng et al. subsequently identified a number of corrections to the 
reference based on comparisons to additional strains at ambiguous positions and open 
reading frame clone sequence data [13].  Their corrections included 58 single base   - 9 - 
pair differences and 63 insertions and deletions.  Similarly, we identified 59 single 
base pair differences as well as 95 insertions and deletions between N16961* and the 
N16961 reference [12] (Figure 2B). 
To validate variant calls where the N16961* sequence differs from the corresponding 
reference, we examined the positions corresponding to those differences, using the 
Microbial Genome Browser alignment.  Positions that differ between the reference 
sequence and the new isolates may represent errors in the reference sequence, false 
positive SNP calls, or mutations introduced during lab passage of the strains.  If the 
discrepancy is due to an error in the reference sequence, then the sequences of 
additional strains in the alignment (O395 and MO10 for the N16961 sequence, 
N16961 and MO10 for the O395 sequence) are likely to agree with our variant call 
and disagree with the reference (Supplementary Figure S2).  For 54 of the 59 
differences, the alignments to strains O395 and MO10 support our new calls in 
N16961* (Supplementary Figure S2).  Alignment to the additional strains supports all 
but one of the 95 insertions and deletions identified between N16961 and N16961*, 
consistent with the interpretation that the discordant positions correspond to errors in 
the reference sequence.  We combined the corrections to the N16961 reference 
sequence previously identified by Feng et al. [13] with the validated variants that we 
identified to generate an updated list of sequence corrections (Supplementary Table 
S5). 
Comparison to O395 Sanger and O395 ABI/454 sequences 
To identify positions at which the sequence differed across multiple technologies, we 
compared the O395* sequence to the O395 Sanger and ABI/454-sequenced references 
([GenBank:CP000626, GenBank:CP000627] and [GenBank:CP001235,   - 10 - 
GenBank:CP001236],	 ﾠrespectively).  We detected 3 SNPs between the O395* isolate 
and the Sanger-sequenced reference.  BLAST queries indicated that in closely related 
strains, the sequence matches the reference at the position of these SNPs.  However, 
manual examination of the SNP positions indicated that they are likely to be real 
variants, suggesting that they may have been introduced during laboratory passage of 
the O395 isolate (Supplementary Figure S3).  We did not detect any insertions or 
deletions between the O395* sample and the O395 Sanger-sequenced reference.  
Between the O395* sequence and the ABI/454-sequenced O395 reference (Figure 
2B), we detected seven additional single-base pair differences, four deletions, and one 
insertion.  The accuracy of our Illumina calls at nine of these twelve positions is 
supported by their agreement with the Sanger-sequenced reference; for the other three 
positions, the Sanger-sequenced reference agrees with the ABI/454 calls. 
Comparison to PacBio sequences:  
We compared three of the isolates that we sequenced (N16961*, H1*, and H2*) to 
previously published PacBio sequences for these same isolates (Figure 2C) [8]. In the 
N16961* sample, 83% of the SNPs that we identified (49/59 differences) were also 
present in the PacBio-based SNP calls.  We identified ten SNPs not found in the 
PacBio variant calls, seven of which are validated by alignment to additional strains.  
Chin et al. reported five SNPs that we did not detect.  Four of the five variants 
identified uniquely in the PacBio-based calls lie in repetitive regions of the genome, 
and these calls are supported by alignment to additional strains.  The remaining SNP 
is not supported by alignment to additional strains.  Although the majority of single 
nucleotide variant calls were consistent across platforms, only 55% of our Illumina-
based insertions and deletions were also found using PacBio sequencing (52/95   - 11 - 
indels).  We identified 43 insertions and deletions in the N16961* sample not 
identified in the PacBio sequencing, and Chin et al. reported seven insertions and 
deletions that we did not recover.  Only one of the seven insertions and deletions 
unique to the PacBio sequence is supported by alignment to additional strains, 
suggesting that the Illumina-based sequencing of the N16961 strain provided more 
sensitive and specific detection of insertions and deletions than the PacBio-based 
sequencing. 
We also compared the variants identified in the H1 and H2 isolates relative to the 
N16961 reference by PacBio sequencing (H1, H2) with those identified by Illumina 
sequencing (H1*, H2*) (Figure 2C).  Ninety-five percent (121/128) of the SNPs we 
identified in H1* were identified in the PacBio sequencing as well, while 83% (111 / 
133) of the SNPs we called in H2* were also called in the PacBio sequencing.  Thirty-
one SNPs were identified uniquely in the PacBio sequencing of H1, while 28 SNPs 
were identified uniquely in the PacBio sequencing of H2.  Many of the variant calls 
(11 in H1, 12 in H2) that were identified only by PacBio sequencing lie in repeat 
regions of the genome, suggesting that the long PacBio reads may facilitate detection 
of SNPs in repetitive regions of the genome that are difficult to recover using the 
shorter Illumina reads.  Of the insertions and deletions that we identified in H1* and 
H2*, only 20-30% (3/9 for H1, 2/10 for H2) were also recovered in the PacBio-based 
calls.  The PacBio-based sequencing identified 16 insertions and deletions in H1 and 
18 in H2 not found in the Illumina-based calls.  Thus, while both the Illumina-based 
and the PacBio-based sequencing identified similar SNPs, the insertion and deletion 
calls were highly divergent between the two approaches. 
Identifying SNPs, insertions, deletions, and structural variation across isolates   - 12 - 
Analysis of an O139 serogroup isolate from Bangladesh 
The O139 serogroup isolate from Bangladesh (DB_2002) was collected in Dhaka in 
2002 and has not been previously sequenced.   Relative to the N16961 reference 
strain, the isolate has deletions in the VPI-II genomic island, the superintegron, and a 
region on chromosome 1 associated with O antigen synthesis which contains genes 
involved in lipopolysaccharide and sugar synthesis/modification.  The DB_2002 
isolate contains two long regions that are absent from the N16961 reference.  A 
35,000-base pair region in the assembly of DB_2002 matches a region in an O139-
serogroup strain from southern India that encodes genes for O-antigen synthesis 
[GenBank:AB012956.1].  The DB_2002 assembly also contains an 84,000-base pair 
region matching SXT integrative and conjugative element sequences in GenBank.   
The genomic content of the DB_2002 isolate is similar to that of other O139 
serogroup isolates. Phylogenetic analysis indicates that DB_2002 clusters closely with 
an O139 serogroup isolate from India (MO10, [GenBank:AAKF03000000]) (Figure 
3).   The deletions in the superintegron, absence of the VPI-2 genomic island, 
presence of the SXT region, and differences in O antigen genes are characteristic of 
other O139-serogroup isolates [14][15].  
Analysis of Dominican Republic and Haitian isolates 
The Haitian and Dominican Republic isolates cluster closely together and group in the 
phylogenetic tree with other seventh pandemic strains (Figure 3).  Among the isolates 
in our phylogeny, the Haitian and Dominican Republic strains cluster most closely 
with strains from Bangladesh (CIRS101, [GenBank:ACVW00000000] and MJ-1236, 
[GenBank:CP001485, GenBank:CP001486]).  In the alignments used to construct the 
phylogeny, there are an average of 12 substitutions between the newly sequenced   - 13 - 
Haitian/Dominican Republic isolates and CIRS101, and an average of 46 substitutions 
between the Haitian/Dominican Republic isolates and MJ-1236.	 ﾠ
To further characterize the Haitian and Dominican Republic isolates, we identified 
deletions and copy number variation relative to reference sequences (Figure 4).  In all 
Haitian and Dominican Republic isolates, deletions were observed in the VSP-2 and 
superintegron regions.  There are also deletions in the SXT region of the Haitian and 
Dominican Republic isolates relative to the MJ-1236 reference strain from 
Bangladesh (Supplementary Figure S1).  To identify novel insertions, we aligned a 
150x-coverage sample of N16961* reads to the de novo assembly of each Dominican 
Republic and Haitian isolate.  All 1000-base pair windows in the de novo assemblies 
of the Haitian and Dominican Republic isolates to which N16961* reads did not map 
matched SXT integrating conjugative element sequences in GenBank, suggesting that 
no additional large insertions are present in the genomes of these isolates. 
The four isolates from Haiti and the Dominican Republic are nearly identical in 
genomic sequence, consistent with a clonal origin for the epidemic.  We identified 
three SNPs between the Haitian and Dominican Republic isolates, as well as one 
additional mutation in one of the Haitian isolates (Table 2).  No sequence differences 
were identified between isolates H1* and H3, and no large-scale structural variation 
was observed across the Haitian and Dominican Republic isolates. 
Functional annotation of variants in Haitian and Dominican Republic cholera strains 
The four isolates from Haiti and the Dominican Republic (DR1, H1*, H2*, and H3) 
are nearly identical in genomic sequence and share 126 variants relative to the 
N16961 reference.  Seventy-three of these variants are non-synonymous mutations in 
coding genes.  Notably, a number of the non-synonymous mutations occur in the   - 14 - 
same gene, or in genes with similar function, potentially indicating adaptive 
convergence.  These include three mutations in the cholera enterotoxin (B subunit), 
and two mutations in MSHA biogenesis proteins (MshJ and MshE), which are 
involved in bacterial adhesion [16].  There are also two mutations that lie in two 
distinct DNA mismatch repair proteins, and two mutations in two outer membrane 
proteins, OmpV and OmpH. 
In order to identify purifying or positive selection between the N16961 reference and 
the Haitian/Dominican Republic V. cholerae strains, we simulated random mutations 
in the cholera genome.  To simulate random point mutations, we selected a genomic 
position uniformly at random, looked up the nucleotide at that position, and then 
randomly selected one of the three other possible bases at that position.  We set the 
number of mutations equal to the number of differences between the N16961 
reference and the Haitian/Dominican strains, and repeated the simulation 1000 times.  
At each iteration, we identified changes encoding non-synonymous substitutions 
(encoding a different amino acid than the original base, or a stop codon).  When 
substitutions between each pair of nucleotides occurred with equal probability, 
synonymous changes were over-represented in the Haitian/Dominican Republic 
strains relative to the simulated data (p<0.01), suggesting purifying selection.  
However, with transitions twice as likely as transversions, the enrichment of 
synonymous changes in the actual sequences relative to the simulation was not 
significant (p=0.1). 
We identified four mutations that occurred within the Haitian and Dominican 
Republic isolates (Table 2), one in the SXT region, one in the CTX region, and two in 
the core genome.  Three point mutations separated the Dominican Republic isolate   - 15 - 
from the Haitian isolates.  These include a synonymous change in the pyruvate-
flavodoxin oxidoreductase gene and a nonsynonymous substitution in transposase in 
the SXT region of the genome; both were also identified by Reimer et al [9].  The 
third mutation separating the Dominican Republic and Haitian isolates is either within 
(according to [17]) or upstream (according to [GenBank:AE003852.1]) of the rstA 
gene, in the CTX region of the genome.  The mutation upstream of rstA is in a region 
identified as bound by RstR in a DNAse I protection assay [17].  We also identified a 
non-synonymous mutation unique to one of the Haitian isolates in the tagA-related 
gene. 
Conclusions  
The three Haitian isolates, the Dominican Republic isolate, and the other isolates that 
we have sequenced provide insight into the changes in V. cholerae over the course of 
the recent epidemic in Hispaniola.  We identified four unique SNPs in individual 
Haitian and Dominican Republic cholera strains, in comparison to all other Haitian 
and Dominican Republic strains.  One of these mutations is in the SXT region, one is 
in the CTX region, and two are in the core genome.  These mutations include three 
mutations between the Haitian and Dominican Republic isolates, as well as one 
mutation unique to a single Haitian isolate.  Our observation of three SNPs between 
isolates that are separated by three months is consistent with a recent estimate of an 
accumulation rate of 3.3 SNPs/year in the core V. cholerae genome [18].   
The Haitian epidemic illustrates the transmission of V. cholerae across geographical 
boundaries.  Multiple studies [8][9][10][19] have suggested that the Haitian cholera 
outbreak strain is likely to have originated in South Asia, and our analysis supports 
this conclusion.  Clinical cases linked to the Haitian cholera strain have occurred in   - 16 - 
the Dominican Republic and in travelers who have recently visited the region.  Thus, 
the use of whole-genome sequencing to trace the evolution of a strain involved in an 
ongoing outbreak is clinically relevant both for understanding an existing epidemic 
and for tracking related cases occurring in other regions.   
Whole-genome sequencing of disease-causing organisms can reveal genetic 
differences between isolates that may be driven by adaption to new host or 
environmental factors.  One of the mutations we identified between the Dominican 
Republic and Haitian isolates is in a region reported to be bound by the transcriptional 
repressor RstR [17], suggesting that this mutation might affect regulation of gene 
expression.  This mutation is located upstream of the rstA gene, which is necessary for 
replication of the CTX phage genome [20].  The mutation in the Haitian isolate H2* is 
located in TagA-related protein.  TagA-related protein is secreted extracellularly by V. 
cholerae [21] and is a homolog of TagA, which has mucinase function [22].  
Sequencing of additional isolates from this outbreak over time is likely to provide 
further clues on the evolutionary dynamics of the V. cholerae genome. 
Since even a single base pair mutation may have functional significance, accurate and 
complete detection of sequence variation is important.  Understanding the effect of 
technical variables such as sequencing platform and depth of coverage is key to 
identifying genomic changes over the course of an epidemic.  By sequencing to a high 
depth of coverage and re-sequencing strains that were previously sequenced using a 
variety of technologies, we were able to compare variant detection across multiple 
sequencing platforms and depths of coverage.  We found that 50-fold coverage is 
sufficient for genome assembly and for the detection of most sequence variants, 
although some additional variants are detected at higher coverage depths.  The   - 17 - 
majority of variant calls, insertions, and deletions are identified across the isolates 
regardless of sequencing technology.  However, we also identified a set of sequence 
variants, insertions, and deletions that were observed uniquely in each platform.  The 
high depth of coverage and low error rate of our Illumina sequencing permits accurate 
detection of sequence variants, insertions, and deletions.  The long reads produced by 
the PacBio technology allows the identification of some additional variants, 
particularly in repeat regions.  As increasing quantities of sequence data become 
available and new sequencing technologies emerge, further work will be needed to 
identify the effects of sequencing platform and analysis pipeline on the genome-wide 
identification of variants. 
The increasing speed and decreasing cost of whole-genome sequencing permits the 
rapid characterization of microbial isolates over the course of an epidemic.  Whole-
genome sequencing can be used to track genomic evolution and functional variation 
in real time, to identify patterns of disease spread within a region, and to identify the 
source of an epidemic by tracing relationships to other strains around the world.  
Whole-genome sequencing is a powerful epidemiological tool whose applications 
towards understanding infectious disease are only beginning to be explored. 
Methods 
V. cholerae samples 
We sequenced seven V. cholerae isolates.  These samples include three clinical 
isolates from the cholera outbreak in Haiti isolated in October 2010, one clinical 
isolate from a cholera patient returning to the U.S. from the Dominican Republic 
isolated in January 2011, the V. cholerae O1 El Tor reference strain N16961 
(Bangladesh, 1971 outbreak), the V. cholerae O1 classical reference strain O395   - 18 - 
(India, 1965), and a 2002 V. cholerae O139 clinical isolate from Bangladesh (Table 
1).  The three Haitian isolates were all collected within days of each other in a single 
hospital in the Artibonite Department.  Four of the seven samples have been 
previously sequenced using different sequencing technologies, and we denote these 
samples with an asterisk (*).  Thus, we denote the samples from Haiti as H1*, H2*, 
and H3; the sample from the Dominican Republic as DR1; the samples from 
Bangladesh as N16961* and DB_2002; and the O1 classical reference strain from 
India as O395*. 
Sample Preparation/Isolation 
We obtained clinical isolates (H1, H2, H3, DR1, DB_2002) from spontaneously 
passed human stool samples of patients with a diagnosis of cholera.  All patients 
received standard medical treatment for cholera, appropriate to their medical 
condition.  Bacteria were recovered from discarded stool specimens; no patient 
identifiers were collected and this was judged to be research exempt from human 
studies approvals by the appropriate Institutional Review Boards.  Bacterial isolates 
were shipped from Haiti (H1, H2 and H3) and Bangladesh (DB_2002) to the U.S. 
following acquisition of appropriate licenses.  DR1 is a clinical isolate from a cholera 
patient returning to the U.S. from the Dominican Republic.  Isolates were confirmed 
as V. cholerae by standard biochemical assays and standard immunoagglutination 
assays.  N16961 and O395 are common laboratory stock isolates (corresponding to 
ATCC 39315 and 39541 respectively) that have been maintained in glycerol at -80 
degrees C.  
Illumina-based whole genome sequencing   - 19 - 
We extracted DNA from V. cholerae strains using QiagenDNEasy (Qiagen, Valencia, 
CA).  For Haitian strain H1* and Dominican Republic strain DR1, we fragmented 
samples by nebulization at 55 psi for four minutes.  To isolate a 200bp band, we ran 
the fragmented DNA on the Pippin Prep gel system (Sage Science, Beverly, MA).  
We processed samples H1* and DR1 using the commercial genomic DNA library 
preparation protocol (Illumina, San Diego, CA).  Briefly, we end-repaired, 3’- 
adenylated, and adapter-ligated DNA fragments using standard Illumina adapters.  We 
selected libraries by size and enriched by PCR for 15 cycles. 
We received the remaining V. cholerae isolates (Table 1) at a later date and 
fragmented DNA from these isolates to approximately 200bp using a Covaris 
shearing instrument.  We prepared the fragmented DNA for sequencing using the 
commercial Illumina protocol for TruSeq DNA library preparations (Illumina, San 
Diego, CA).  We selected libraries by size and enriched by PCR for 15 cycles to 
maintain consistency between methods. 
We clustered the resulting libraries for all isolates in individual flow cell lanes and 
sequenced for 100 cycles on an Illumina HiSeq Analyzer, using paired-end 
technology.  We filtered sequence reads based on quality scores.  The resulting reads 
had high depth of coverage (> 2000x for each isolate when mapped to the N16961 
reference genome using MAQ, a short read alignment tool [23]), enabling de novo 
assembly. 
De novo assembly 
Using the Velvet genome assembler (v. 1.0.19) [24], we assembled the genomes on a 
subsample of reads from each isolate (69x-176x coverage when mapped using MAQ 
to the N16961 reference genome).  We used the VelvetOptimiser script (version   - 20 - 
2.1.17) to optimize the assembly parameters.  We assessed the performance of the 
assembler on sets of reads at varying depths of coverage (Figure 1A). 
Comparison of sequence variants across sequencing technologies 
We aligned subsamples of N16961* and O395* reads (150x coverage) to the 
corresponding published full genomes (Sanger-sequenced N16961 and Sanger-
sequenced O395; Heidelberg et al., 2001, GSCID).  We identified SNPs, insertions, 
and deletions as described above (Supplementary Table S3).  We also compared the 
PacBio-based variant calls for isolates H1, H2, and N16961 [8] to variant calls for 
H1*, H2*, and N16961* (Figure 2A).  To validate differences between the N16961* 
sequence and the N16961 published reference, we examined the alignment to 
additional strains using the Microbial Genome Browser [25].  Since the Microbial 
Genome Browser alignment track was not available for the O395 sequence, we used 
BLAST to examine the corresponding bases in related strains for positions at which 
the O395* sequence differed from the Sanger-sequenced O395 reference. 
Identifying SNPs, insertions, deletions, and structural variation across isolates 
We called SNPs, insertions, and deletions on three non-overlapping 150x subsamples 
of reads.  SNPs, insertions, and deletions shared among all three subsamples are 
reported here (Supplementary Table S2).  Using the BWA short-read aligner [26], we 
aligned each 150x read subsample to the N16961 reference genome 
[GenBank:AE003852, GenBank:AE003853].  For the O395* sample, we aligned 
instead against the Sanger-sequenced O395 reference [GenBank:CP000626, 
GenBank:CP000627].    - 21 - 
We recalibrated base quality scores and performed realignment around insertions and 
deletions using the Genome Analysis Toolkit, a framework for analyzing next-
generation sequence data [27].  We called SNPs using the variant detection tool 
Varscan [28], requiring a minimum SNP frequency of 25% to allow for SNP calling 
in repeat regions of the genome.  To reduce sequencing artifacts, we required that the 
variant call be represented on reads in both directions, with no more than three-
quarters of the variant calls on reads in the same direction when fewer than 90% of 
the reads carried the variant call.  
We identified small insertions and deletions on the realigned, recalibrated pileup files 
(aligned to the N16961 reference genome) using Varscan, requiring a 75% variant 
frequency.  To restrict the variant set to differences with the reference genome, we 
removed variants identified between the N16961* isolate and the N16961 reference.  
For functional annotation of SNPs, we used the snpEff software [29]. 
To identify large-scale structural variants, we examined variation in the depth of 
coverage in 1000-base pair windows when a sub-sample of the reads was aligned 
against the N16961 and MJ-1236 [30] reference genomes, similar to the approach in 
Chin et al. [8].  To identify large insertions relative to the N16961* genome, we used 
MAQ to align a 150x-coverage subsample of the N16961* reads to the de novo 
assembly for each isolate.  We characterized all thousand base pair windows without 
aligned reads using a BLASTn search against the “nr/nt” database. 
In order to identify high-confidence sequence differences across the Haitian and 
Dominican Republic isolates, we used Fisher’s exact test based on counts of reads 
aligned at each position to the N16961 and MJ-1236 reference genomes, similar to the 
approach implemented in the Nesoni tool [31].  We eliminated reads with quality   - 22 - 
scores with a greater than 1% estimated error rate from the count, as well as positions 
at which more than three-quarters of variant calls were on reads in the same direction.  
We removed variant calls based on sequence reads with multiple differences from the 
reference as well as at positions where more than a quarter of the reads in both 
isolates carried the variant call.  We reported high-confidence SNPs with Bonferroni-
corrected p < 0.01. 
Constructing a phylogeny 
To construct a phylogeny, we identified genes conserved across all newly sequenced 
isolates as well as 33 previously sequenced V. cholerae isolates (Supplementary Table 
1).   We included all genes for which the top BLAST hit to the N16961 reference gene 
had at least 70% identity in all strains.  To eliminate paralogs, we required the next 
best hit to be less than 0.8 times as similar as the best hit.  We constructed a multiple 
sequence alignment for the nucleotide sequences of the 1740 genes meeting these 
criteria using the multiple sequence alignment tool MUSCLE [32].  We concatenated 
the alignments of genes present in all strains, and constructed a maximum-likelihood 
phylogeny with RaxML [33], using the General Time Reversible model of nucleotide 
substitution. 
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Figures 
Figure 1 - Fiftyfold coverage suffices for whole-genome assembly and 
detection of most sequence varients. 
(A) The N50 of the assembly, shown over a range of coverage depths (5x-250x), 
rapidly increases up to 50x coverage, and then plateaus. The median N50 of 
assemblies of five disjoint sets of reads at each depth of coverage is shown.  (B) The 
number of SNPs detected increases rapidly up to 50x coverage, and gradually 
thereafter. (C) The number of insertions and deletions detected increases rapidly up to 
20x coverage, and plateaus after 50x coverage.  SNPs, insertions, and deletions in all 
isolates except for O395* are called relative to the N16961 genome 
[GenBank:AE003852, GenBank:AE003853]. For the O395* sample, due to the large 
number of differences (>20,000 SNPs) from the N16961 reference, SNPs, insertions, 
and deletions were identified instead against the Sanger-sequenced O395 reference 
[GenBank:CP000626, GenBank:CP000627]. 
Figure 2  - Comparison of SNPs, insertions, and deletions called across 
sequencing technologies.   
(A) List of published sequences for the four previously sequenced isolates (N16961, 
O395, H1, and H2) examined in this study.  (B) Comparison of new Illumina 
sequences to GenBank references.  The number of differences identified in the new 
sequence relative to the GenBank reference is shown in the table, with the number of 
differences confirmed by alignment to additional strains shown in parentheses.  (C) 
Comparison of Illumina-based and PacBio-based SNP, insertion, and deletion calls 
relative to the Sanger-sequenced N16961 reference [GenBank:AE003852, 
GenBank:AE003853]. The number of variants called in PacBio sequencing only (red   - 28 - 
circle), in Illumina sequencing only (blue circle), or in both (intersection) are shown.  
For the N16961 sequences, the number of differences confirmed by alignment to 
additional strains is shown in parentheses. For H1 and H2, only variants that do not 
correspond to likely errors in the N16961 reference sequence are counted. 
Figure 3  - Phylogeny of the sequenced strains and 33 previously sequenced V. 
cholerae isolates.  
We constructed a maximum-likelihood phylogeny using RaxML based on genes 
conserved across all newly sequenced isolates as well as 33 previously sequenced V. 
cholerae isolates. The isolates sequenced in our study are shown in red. 
 
Figure 4 - Variation in depth of coverage of the sequenced isolates, based on 
read alignments of the seven sequenced strains against the N16961 reference 
genome. 
Chromosome 1 (A) and chromosome 2 (B) are shown.  The depth of coverage of 1000 
base pair windows of 150x average coverage subsamples of the DR1 (outermost 
circle), H1*, H2*, H3, N16961*, O395*, and DB_2002 (innermost circle) isolates is 
displayed.  Regions at low depth of coverage (<12x) are shown in red, while regions 
at high depth of coverage (>240x) are shown in blue.  The depth of coverage in each 
window is displayed using the Circos tool [34].  Genomic islands as defined in [15] 
and the superintegron region as defined in [8] are shown. 
 
Tables 
Table 1  - Vibrio cholerae Isolates sequenced. 
An asterisk (*) denotes samples that have been previously sequenced.    - 29 - 
 
Sample  Origin  Date  V. cholerae 
serogroup and 
biotype 
Previous 
sequencing 
method 
DR1  Dominican Republic  January 2011  O1 El Tor   
H1*  Artibonite Province, 
Haiti 
October 2010  O1 El Tor  PacBio [8] 
H2*  Artibonite Province, 
Haiti 
October 2010  O1 El Tor  PacBio [8] 
H3  Artibonite Province, 
Haiti 
October 2010  O1 El Tor   
N16961*  Bangladesh  1971  O1 El Tor  Sanger [12], 
PacBio [8]  
O395*  India  1965  O1 classical  Sanger (GSCID), 
ABI/454 [13] 
DB_2002  Bangladesh  2002  O139   
 
Table 2  -  Unique single nucleotide polymorphisms identified in individual 
Haitian and Dominican Republic cholera strains, in comparison to all other 
Haitian and Dominican Republic strains. 
Isolate  Chrom
osome 
Location  Ref 
Allele 
Variant 
Allele 
Associated Gene  Type of 
Change 
DR1  1  1565917/1
572833* 
T  C  rstA  Upstream 
of gene 
H2*  2  166022  C  T  TagA-related protein  Nonsyn 
DR1  2  467913  G  A  Pyruvate-flavodoxin 
oxidoreductase 
Syn 
DR1  1  3055641
†  A  C  Transposase Tn3 family 
protein 
Nonsyn 
*The two locations provided for the rstA-related mutation correspond to the 
two copies of this gene in the N16961 reference strain. 
†While all other genomic coordinates in the table are specified with respect to 
the N16961 reference strain, this variant lies in the SXT region, absent from 
the N16961 reference.  Here, the genomic coordinates are specified with 
respect to the MJ-1236 reference. 
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Additional file 11 – Supplementary figure S5: Alignments of DR1 reads to the 
N16961 reference at the positions where the DR1 and Haitian V. cholerae isolates 
differ. 